• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Bull market
Biotech

Biotech IPOs here to stay after another record-breaking listing

Elon Musk's SpaceX may be igniting global headlines with the company's astronomical IPO, but biotech listings saw their own record-breaker this week.
Will Maddox Jun 12, 2026 11:00am
NVS

Novartis dystrophy data tee up regulatory talks on Avidity drug

Jun 12, 2026 4:30am
FranchiseKeyvisualsOncologyLevel2Digital-nonepng

Could engaging the immune system improve AML outcomes?

Brought to you by Ipsen
London

Fierce Biotech heading to UK amid London Life Sciences Week

Jun 11, 2026 4:57am
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

3 Genentech VPs among those dismissed in latest layoff round

Jun 11, 2026 2:30pm
A blue-toned graphic showing assorted pills and capsules scattered across a close-up of a 100 bill with Benjamin Franklin

Ipsen R&D chief on pipeline discipline and 2026 milestones

Jun 12, 2026 9:57am
More News

Perrigo CEO ousted over ‘personal conduct’—Chutes & Ladders

Jun 12, 2026 8:30am
Fierce Pharma

Inside Astellas CEO's plan to counter Xtandi's patent cliff

Jun 11, 2026 6:00pm
Fierce Healthcare

HHS ramps up AI use cases, with most in pre-deployment: BPC

Jun 11, 2026 2:00pm
Fierce Pharma

Novo reports data breach, urges patients to 'remain vigilant'

Jun 11, 2026 1:18pm
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings